4.5 Article

Metabolism of (R)-Praziquantel versus the Activation of a Parasite Transient Receptor Potential Melastatin Ion Channel

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Chemistry, Medicinal

Praziquantel-50 Years of Research

Andreas Waechtler et al.

Summary: Investigations on praziquantel (PZQ) started fifty years ago and it is still the drug of choice for schistosomiasis. PZQ is used in veterinary medicine in combination with antinematode drugs. Additionally, the primary target of PZQ, a transient receptor potential channel, has been discovered. There are also efforts to develop pure (R)-PZQ for human application, specifically for pediatric use. The knowledge of the binding pocket of PZQ allows for designing synthesis of next-generation PZQ-derivatives for target-site directed screening.

CHEMMEDCHEM (2023)

Article Infectious Diseases

Efficacy, safety, and palatability of arpraziquantel (L-praziquantel) orodispersible tablets in children aged 3 months to 6 years infected with Schistosoma in Cote d'Ivoire and Kenya: an open-label, partly randomised, phase 3 trial

Eliezer K. N'Goran et al.

Summary: This study evaluated the efficacy, safety, palatability, and pharmacokinetics of arpraziquantel tablets for treating schistosomiasis in preschool-aged children. The results showed that arpraziquantel tablets demonstrated good efficacy and safety in the treatment of schistosomiasis in preschool-aged children.

LANCET INFECTIOUS DISEASES (2023)

Article Multidisciplinary Sciences

Natural variation in the binding pocket of a parasitic flatworm TRPM channel resolves the basis for praziquantel sensitivity

Claudia M. Rohr et al.

Summary: The drug praziquantel (PZQ) is the key clinical therapy for treating schistosomiasis and other infections caused by parasitic flatworms. A recent study identified a target for PZQ in parasitic flatworms, but little is known about its properties in other flatworms. This study found that the PZQ target is present in all parasitic flatworms and showed different sensitivities to PZQ among different flatworms. The study also identified variations in the binding pocket of the PZQ target, which explains why PZQ is effective against specific infections.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Editorial Material Chemistry, Medicinal

Alternatives to Praziquantel for the Prevention and Control of Schistosomiasis

Thomas Spangenberg

Summary: Schistosomiasis, a neglected tropical disease caused by infection with parasitic blood flukes, affects millions worldwide with limited treatment options. The World Health Organization calls for the development of new drugs to eliminate this public health problem.

ACS INFECTIOUS DISEASES (2021)

Article Cell Biology

Mechanism of praziquantel action at a parasitic flatworm ion channel

Sang-Kyu Park et al.

Summary: This study reveals the mechanism of action of PZQ on schistosomes, activating the TRPMPZQ channel to cause calcium entry and worm paralysis. PZQ activates TRPMPZQ homologs in schistosomes, but is ineffective against Fasciola hepatica.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Infectious Diseases

Identification of novel modulators of a schistosome transient receptor potential channel targeted by praziquantel

Evgeny G. Chulkov et al.

Summary: This study optimized a high-throughput screening method for Schistosoma mansoni TRPMPZQ activity, leading to the discovery of a novel activator of Sm.TRPMPZQ and numerous potential blockers. The new activator, though distinct from PZQ, was similar to a known chemical entity identified through phenotypic screening.

PLOS NEGLECTED TROPICAL DISEASES (2021)

Article Pharmacology & Pharmacy

Insights into Praziquantel Metabolism and Potential Enantiomeric Cytochrome P450-Mediated Drug-Drug Interaction

Gloria Vendrell-Navarro et al.

DRUG METABOLISM AND DISPOSITION (2020)

Review Biochemistry & Molecular Biology

Recent Progress in TRPM8 Modulation: An Update

Rosario Gonzalez-Muniz et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Medicine, Research & Experimental

Relative Bioavailability of Orally Dispersible Tablet Formulations of Levo- and Racemic Praziquantel: Two Phase I Studies

Wilhelmina Maria Bagchus et al.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2019)

Article Infectious Diseases

Activation of host transient receptor potential (TRP) channels by praziquantel stereoisomers

Gihan S. Gunaratne et al.

PLOS NEGLECTED TROPICAL DISEASES (2018)

Article Microbiology

Activity of Praziquantel Enantiomers and Main Metabolites against Schistosoma mansoni

Isabel Meister et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)

Article Biochemistry & Molecular Biology

Synthesis and SAR Studies of Praziquantel Derivatives with Activity against Schistosoma japonicum

Wen-Long Wang et al.

MOLECULES (2013)

Article Cell Biology

Characterisation of TRPM8 as a pharmacophore receptor

Matthias Boedding et al.

CELL CALCIUM (2007)